PPC has developed a series of best practices materials including Model Policies and supporting “Fast Facts” background issue papers with facts and figures, discussion of legal and policy issues, examples of pilot projects and early adopters, and resources for further research. Best practice materials strategically address issues and industry practices that contribute to the high cost of prescription drugs in the United States.

Pharmacy Benefit Managers (PBM)
PBMs manage the majority of pharmacy benefit programs in the country. How do they work? How can states, employers and health plans insure that PBMs work for them, and that negotiated rebates and cost savings are fully passed through to benefit consumers?

Saving Medicaid Dollars Without Capping Prescriptions
Research is clear: caps on prescriptions hurts patients and in the long run, doesn’t save money. What are some alternative policy options already in operation around the country which save significant Medicaid dollars without affecting patient health?

Disclosure of Clinical Trials
Shouldn’t consumers, providers and government programs know about important information on the efficacy and side effects associated with prescription drugs? Policies to require disclosure of clinical trials data.

Purchasing Pools and PDLs
States and employers are joining together in purchasing pools to leverage better prices from the manufacturers. The most effective of these are combined with a Preferred Drug List (PDL). What works, and how much can be saved?

Addressing Fraud through a State False Claims Act
States are eligible to recoup millions of dollars for over-billing, improper marketing, pricing fraud, and failure to pass through rebates if they have a False Claims Act.

Reining in Excessive Prices
Are drug manufacturers gouging consumers with overpriced drugs? There are several policy options that have been adopted by states. What are the legal and practical considerations in developing policies to rein in drug costs?

Academic Detailing
Also known as prescriber support and education, is the service of sending trained clinicians to physician offices on order to present the best available, objective scientific evidence in a therapeutic area. Such encounters promote the most appropriate, clinically judicious use of prescription drugs a well as positive overall patient care.